The founding team brings 15 years of regional MedTech experience, including fertility-technology partnerships across Malaysia, Singapore, Indonesia, Thailand and China. APAC is not a new market for us — decentralized embryo culture is.


Yve has negotiated and managed distribution and licensing agreements totalling $30M+ in direct sales and recurring revenue across APAC.
Yve and Othman have successfully navigated regulatory approval and market entry across Malaysia, Singapore, China, Indonesia and Thailand.
The team has established working relationships with major fertility operators, hospital systems and clinicians across the region.
Questions about Eve, EVEA™, or partnership opportunities — reach out.
Contact us →